Literature DB >> 16116124

White matter lesion severity in male and female patients with Fabry disease.

A Fellgiebel1, M J Müller, M Mazanek, K Baron, M Beck, P Stoeter.   

Abstract

In male patients with Fabry disease (FD), significant age-related cerebral white matter lesions (WMLs) can be found. Although characteristic symptoms including cerebrovascular events are highly prevalent also in females with FD, cerebral structural changes have not been investigated in female FD patients yet. The authors quantified the WML load of 13 male and 14 age-matched female patients with FD and could demonstrate a comparably high frequency and severity of WMLs in both groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116124     DOI: 10.1212/01.wnl.0000173030.70057.eb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Authors:  Andreas Fellgiebel; Dominik O Wolf; Edwin Kolodny; Matthias J Müller
Journal:  J Inherit Metab Dis       Date:  2011-09-20       Impact factor: 4.982

Review 2.  [Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge].

Authors:  Frank Weidemann; Markus Niemann; Claudia Sommer; Meinrad Beer; Frank Breunig; Christoph Wanner
Journal:  Med Klin (Munich)       Date:  2010-09-28

3.  Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.

Authors:  Andreas Fellgiebel; Martin Mazanek; Catharina Whybra; Michael Beck; Ralf Hartung; Kay-Maria Müller; Armin Scheurich; Paulo R Dellani; Peter Stoeter; Matthias J Müller
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

4.  Fabry disease: multidisciplinary evaluation after 10 years of treatment with agalsidase Beta.

Authors:  Politei Juan; Amartino Hernan; Schenone Andrea Beatriz; Cabrera Gustavo; Michref Antonio; Tanus Eduardo; Dominguez Raul; Larralde Margarita; Blanco Mariana; Gaggioli Daniela; Szlago Marina
Journal:  JIMD Rep       Date:  2014-05-22

5.  Determinants of white matter hyperintensity burden in patients with Fabry disease.

Authors:  Natalia S Rost; Lisa Cloonan; Allison S Kanakis; Kaitlin M Fitzpatrick; Danielle R Azzariti; Virginia Clarke; Charles M Lourenco; Dominique P Germain; Juan M Politei; György A Homola; Claudia Sommer; Nurcan Üçeyler; Katherine B Sims
Journal:  Neurology       Date:  2016-04-20       Impact factor: 9.910

6.  Cognitive and psychological functioning in Fabry disease.

Authors:  Linda Sigmundsdottir; Michel C Tchan; Alex A Knopman; Graham C Menzies; Jennifer Batchelor; David O Sillence
Journal:  Arch Clin Neuropsychol       Date:  2014-11       Impact factor: 2.813

Review 7.  Stroke and Fabry disease.

Authors:  Miguel Viana-Baptista
Journal:  J Neurol       Date:  2011-10-27       Impact factor: 4.849

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.

Authors:  Laura Fancellu; Walter Borsini; Ilaria Romani; Angelo Pirisi; Giovanni Andrea Deiana; Elia Sechi; Pietro Emiliano Doneddu; Anna Laura Rassu; Rita Demurtas; Anna Scarabotto; Pamela Cassini; Eloisa Arbustini; GianPietro Sechi
Journal:  BMC Neurol       Date:  2015-12-12       Impact factor: 2.474

10.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.